Mapping the brain-spinal cord interaction towards understanding and treatment of movement disordersbroad
Move2Treat · Horizon Europe grant · 2024-07-01–2027-06-30
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2023-PATHFINDEROPEN-01 · scheme HORIZON-EIC · topic HORIZON-EIC-2023-PATHFINDEROPEN-01-01. CORDIS record →
Objective
Movement is one of the most important activities in our everyday life. It is an essential element for maintaining overall health and well-being, with more than 1 billion people globally suffering from a neurological disease that directly affects their movement. Each year, more than 1.5 million people experience a stroke in the EU alone leading to death, paralysis, or some kind of disability; this is a significant burden on healthcare systems with no cure. We must address the questions: How do we move? What is the underlying physical mechanism of the brain-spinal cord interaction that orchestrates the generation of movement? To be able to answer those, a high-performance bi-directional interface is required. Move2Treat explores disruptive science by developing a new brain-spinal cord interface to investigate the associated neuronal circuits. In fact, Move2Treat has 3 distinct breakthroughs: (1) a novel theory on movement generation by rotating ensembles validation the neuronal population activity across central brain regions and the spinal cord. (2) A bi-directional soft-fiber platform as neural interface to brain and spinal cord in freely behaving species. (3) Validation of theory (1) and neural interface (2) in the disease models. The developed theory and implant enable the “next-generation pacemaker of the nervous system” based on the first complete, minimally invasive, wireless, biocompatible and soft multifunctional fiber-based neural interface to map the brain-spinal cord activity by simultaneous stimulation/recording in vivo and real-time with high spatial and temporal resolution. Move2Treat is a European approach to establish technological sovereignty, delivering the “next-generation precision sensing for neurological science”.
Beneficiaries (4)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| DANMARKS TEKNISKE UNIVERSITET | DK | coordinator | €834,634 | |
| ALBERT-LUDWIGS-UNIVERSITAET FREIBURG | DE | participant | €791,891 | |
| KOBENHAVNS UNIVERSITET | DK | participant | €703,996 | |
| TECHNOLOGIKO PANEPISTIMIO KYPROU | CY | participant | €665,528 |
Get the EU Defence Funding Calendar — free
The full calendar of open EU defence and dual-use funding calls, sorted by deadline, updated nightly. Delivered with DFM Analysis, our weekly briefing on who is funding what in European defence.
Or browse all open defence & dual-use calls on the funding calendar →
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; the paid Annual Professional subscription is handled on DFM Analysis.